Mohamed Abouelkhair

Mohamed A Abouelkhair obtained the veterinary degree (B.V.Sc) in May 2009 at Menoufia University, Egypt. He joined the Faculty of veterinary medicine as an assistant lecturer in Bacteriology, Mycology, and Immunology, and earned the M.V.Sc in February 2013 at Menoufia University, Egypt. Then he got the Ph.D in Comparative and Experimental Medicine (CEM) in July 2019 at the University of Tennessee, Knoxville (UTK) College of Veterinary Medicine. Recently, Mohamed A Abouelkhair passed both the General Examination and the Immunology Specialty Examination. He is now a diplomate of the American College of Veterinary Microbiologists (ACVM), certified in ImmunologyMohamed A Abouelkhair currently works as a Post−Doctoral Research Associate in the department of Biomedical & Diagnostic Sciences at the University of Tennessee, Knoxville.

Lab Information

Department of Biomedical and Diagnostic Sciences, University of Tennessee College of Veterinary Medicine

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Immunology 6 Phylogenetic Analysis 5 Bioinformatics and Computational Biology 1 CRISPR / Cas9 1 DNA Sequencing 1 Determination of Protein Concentration by BCA Method 1 Enzyme Linked Immunosorbent Assay (ELISA) 1 Gene Expression 1 Infectious Disease 1 Microbiology 1 Molecular Cloning 1 PCR 0 Plasmid Construction 1 Protein Purification 1 Protein Expression 1 Q-PCR 1 RT-PCR 1 Recombinant Protein Expression 1 SDS-PAGE 1 Vaccine Development 1 Western Blot 1 Protein Dialysis 1

More

  • Post
  • Publication
  • Plasmid
  • Following (2)
  • Follower (3)


This guy hasn’t posted anything yet.

Hot Posts for You

Neutralizing antibodies (NAbs) are critical human immune defense mechanisms against viral infections. NAbs can bind to sites on the virus and inhibit entry of that virus into the host. It is a key parameter to evaluate COVID-19 vaccine efficacy per Guidelines from Development and ...Learn More


This 3D animation shows you how DNA is copied in a cell. It shows how both strands of the DNA helix are unzipped and copied to produce two identical DNA molecules. TranscriptDNA is a molecule made up of two strands twisted around each other in a double helix shape. Each strand is ...Learn More


IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More


"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More


In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More


The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More


This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More


The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More


The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More


  1. Abouelkhair MA, Bemis DA, Giannone RJ, Frank LA, Kania SA. Characterization of a leukocidin identified in Staphylococcus pseudintermedius. PLoS ONE. 2018;13(9):e0204450.

  2. Abouelkhair MA, Thompson R, Riley MC, Bemis DA, Kania SA. Complete Genome Sequences of Three Staphylococcus pseudintermedius Strains Isolated from Botswana. Genome Announc. 2018;6(10)

  3. Abouelkhair MA, Riley MC, Bemis DA, Kania SA. Complete Genome Sequence of Type Strain LMG 22219. Genome Announc. 2017;5(7)

  4. Abouelkhair MA, Bemis DA, Kania SA. Characterization of recombinant wild-type and nontoxigenic protein A from Staphylococcus pseudintermedius. Virulence. 2018. pmid:30052123

  5. Abouelkhair MA, Bemis DA, Giannone RJ, Frank LA, Kania SA. Identification, cloning and characterization of SpEX exotoxin produced by Staphylococcus pseudintermedius. PLoS ONE. 2019 Jul 29;14(7):e0220301.

  6. Abouelkhair MA, Rifkin RE, Grzeskowiak RM, Biris AS, Anderson DE, Bemis DA, Kania SA. 2018. Complete genome sequences of four Staphylococcus aureus sequence type 398 isolates from four goats with osteomyelitis. Microbiol Resour Announc 7:e01174-18.


This guy hasn’t plasmids anything yet.

Hot plasmids

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2024 MolecularCloud